BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 23173124)

  • 1. The role of microRNA in metastatic colorectal cancer and its significance in cancer prognosis and treatment.
    Tokarz P; Blasiak J
    Acta Biochim Pol; 2012; 59(4):467-74. PubMed ID: 23173124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-137, an HMGA1 target, suppresses colorectal cancer cell invasion and metastasis in mice by directly targeting FMNL2.
    Liang L; Li X; Zhang X; Lv Z; He G; Zhao W; Ren X; Li Y; Bian X; Liao W; Liu W; Yang G; Ding Y
    Gastroenterology; 2013 Mar; 144(3):624-635.e4. PubMed ID: 23201162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of microRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression.
    Chen DL; Wang ZQ; Zeng ZL; Wu WJ; Zhang DS; Luo HY; Wang F; Qiu MZ; Wang DS; Ren C; Wang FH; Chiao LJ; Pelicano H; Huang P; Li YH; Xu RH
    Hepatology; 2014 Aug; 60(2):598-609. PubMed ID: 24616020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer.
    Tang JT; Wang JL; Du W; Hong J; Zhao SL; Wang YC; Xiong H; Chen HM; Fang JY
    Carcinogenesis; 2011 Aug; 32(8):1207-15. PubMed ID: 21665895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic implications of serum microRNA-21 in colorectal cancer.
    Menéndez P; Padilla D; Villarejo P; Palomino T; Nieto P; Menéndez JM; Rodríguez-Montes JA
    J Surg Oncol; 2013 Nov; 108(6):369-73. PubMed ID: 23970420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer.
    Kong Y; Bai PS; Sun H; Nan KJ; Chen NZ; Qi XG
    Int J Biochem Cell Biol; 2012 Dec; 44(12):2321-32. PubMed ID: 22903020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SP1 mediates the link between methylation of the tumour suppressor miR-149 and outcome in colorectal cancer.
    Wang F; Ma YL; Zhang P; Shen TY; Shi CZ; Yang YZ; Moyer MP; Zhang HZ; Chen HQ; Liang Y; Qin HL
    J Pathol; 2013 Jan; 229(1):12-24. PubMed ID: 22821729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer.
    Christensen LL; Tobiasen H; Holm A; Schepeler T; Ostenfeld MS; Thorsen K; Rasmussen MH; Birkenkamp-Demtroeder K; Sieber OM; Gibbs P; Lubinski J; Lamy P; ; Laurberg S; Oster B; Hansen KQ; Hagemann-Madsen R; Byskov K; Ørntoft TF; Andersen CL
    Int J Cancer; 2013 Jul; 133(1):67-78. PubMed ID: 23280316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-429 is an independent prognostic factor in colorectal cancer and exerts its anti-apoptotic function by targeting SOX2.
    Li J; Du L; Yang Y; Wang C; Liu H; Wang L; Zhang X; Li W; Zheng G; Dong Z
    Cancer Lett; 2013 Feb; 329(1):84-90. PubMed ID: 23111103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-499-5p promotes cellular invasion and tumor metastasis in colorectal cancer by targeting FOXO4 and PDCD4.
    Liu X; Zhang Z; Sun L; Chai N; Tang S; Jin J; Hu H; Nie Y; Wang X; Wu K; Jin H; Fan D
    Carcinogenesis; 2011 Dec; 32(12):1798-805. PubMed ID: 21934092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased expression of microRNA-625 is associated with tumor metastasis and poor prognosis in patients with colorectal cancer.
    Lou X; Qi X; Zhang Y; Long H; Yang J
    J Surg Oncol; 2013 Sep; 108(4):230-5. PubMed ID: 23861214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-221 promotes colorectal cancer cell invasion and metastasis by targeting RECK.
    Qin J; Luo M
    FEBS Lett; 2014 Jan; 588(1):99-104. PubMed ID: 24269686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-139 inhibits invasion and metastasis of colorectal cancer by targeting the type I insulin-like growth factor receptor.
    Shen K; Liang Q; Xu K; Cui D; Jiang L; Yin P; Lu Y; Li Q; Liu J
    Biochem Pharmacol; 2012 Aug; 84(3):320-30. PubMed ID: 22580051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasion front-specific expression and prognostic significance of microRNA in colorectal liver metastases.
    Kahlert C; Klupp F; Brand K; Lasitschka F; Diederichs S; Kirchberg J; Rahbari N; Dutta S; Bork U; Fritzmann J; Reissfelder C; Koch M; Weitz J
    Cancer Sci; 2011 Oct; 102(10):1799-807. PubMed ID: 21722265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-150 as a potential biomarker associated with prognosis and therapeutic outcome in colorectal cancer.
    Ma Y; Zhang P; Wang F; Zhang H; Yang J; Peng J; Liu W; Qin H
    Gut; 2012 Oct; 61(10):1447-53. PubMed ID: 22052060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-330 regulates the proliferation of colorectal cancer cells by targeting Cdc42.
    Li Y; Zhu X; Xu W; Wang D; Yan J
    Biochem Biophys Res Commun; 2013 Feb; 431(3):560-5. PubMed ID: 23337504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-944 inhibits cell migration and invasion by targeting MACC1 in colorectal cancer.
    Wen L; Li Y; Jiang Z; Zhang Y; Yang B; Han F
    Oncol Rep; 2017 Jun; 37(6):3415-3422. PubMed ID: 28498456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-95 promotes cell proliferation and targets sorting Nexin 1 in human colorectal carcinoma.
    Huang Z; Huang S; Wang Q; Liang L; Ni S; Wang L; Sheng W; He X; Du X
    Cancer Res; 2011 Apr; 71(7):2582-9. PubMed ID: 21427358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma miR-21: a potential diagnostic marker of colorectal cancer.
    Kanaan Z; Rai SN; Eichenberger MR; Roberts H; Keskey B; Pan J; Galandiuk S
    Ann Surg; 2012 Sep; 256(3):544-51. PubMed ID: 22868372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA expression profiles in human colorectal cancers with liver metastases.
    Lin M; Chen W; Huang J; Gao H; Ye Y; Song Z; Shen X
    Oncol Rep; 2011 Mar; 25(3):739-47. PubMed ID: 21174058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.